David Wang

Private Equity Investor at

OrbiMed Advisors Private Equity

Finance

Consumer Services

Health Technology

Profile

David Wang, M.D., Ph.D., is a Partner and Senior Managing Director on the Asia team, focused on Greater China.
Previously, he was a Managing Director at WI Harper Group, responsible for healthcare investments in China.
He also previously served as Head of Business Development at Siemens Medical Solutions, where he directed corporate strategy and new businesses in molecular diagnostics and diagnostic imaging.
Dr. Wang was a co-founder and EVP at First Genetic Trust, a personalized medicine company.
During his tenure at Bristol-Myers Squibb, Dr. Wang was Chairman of The SNP Consortium Management Committee, the first group of its kind formed by pharmaceutical and technology industries to support the development of personalized medicine.
He received his M.D.
from Peking University Medical School, and his doctorate in Developmental Biology from California Institute of Technology.

David Wang active positions

Companies	Position	Start
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Private Equity Investor	01/10/2019

All active positions of David Wang

Former positions of David Wang

Companies	Position	End
Healthcare Royalty Partners Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	02/09/2019
Three Arch Partners Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies.	Private Equity Investor	02/04/2013
Access Closure, Inc. Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States	Director/Board Member	01/03/2013

See the detail of David Wang's experience

Training of David Wang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Access Closure, Inc. Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States	Health Technology
Peking University Peking University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Three Arch Partners Three Arch Partners Investment ManagersFinance Three Arch Partners invests in companies located in the US. The firm targets companies operating primarily in healthcare (medical devices, diagnostics and healthcare services) and occasionally biotechnology. The firm provides financing mainly on early stage companies and seldom on later stage healthcare companies. The firm has an investment range from $0.1 million to $15 million, believes in co-investing with other venture capital funds and remains actively involved in their companies.	Finance
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Finance
Healthcare Royalty Partners Healthcare Royalty Partners Investment ManagersFinance Functions as an alternative investment manager	Finance

See company connections